Conference call on the Report on Operations 2014

Invitation to attend Vitrolife’s conference call regarding presentation of the Report on Operations 2014. The presentation will be held in English.

Time: Friday, February 6, 2015 at 10.00 a.m. CET.

Registration can preferably be done in advance under the following link: https://eventreg1.conferencing.com/webportal3/reg.html?Acc=800440&Conf=192144  

or shortly before time of the conference starts on:

Sweden dial in number: +46 (0)8 5052 0110

UK dial in number: +44 (0)20 7162 0077

Conference name: Vitrolife, conference ID: 951116

Vitrolife participants:

Thomas Axelsson,

CEO Mikael Engblom, CFO

The press release for Vitrolife’s Year-end report will be released at 8.30 CET on the same day.

Before the conference call, slides will be available at the company web page, http://www.vitrolife.com/en/Corporate/

A recorded version of the presentation will be available for seven days on number  +46 (0)8 5052 0333 (Sweden) or 020 7031 4064 (UK), access code 951116.

Gothenburg, January 27, 2015

VITROLIFE AB (publ)

For further information, please contact:
Thomas Axelsson, CEO, 46 31 721 80 01
Mikael Engblom, CFO, 46 31 721 80 14

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

_________________________________________________________________________________________________________________

Vitrolife is an international medical device Group. Vitrolife Fertility product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes

Vitrolife  has approximately 320 employees and the company's products are sold in almost 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm , Mid Cap.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com/

Tags:

About Us

Vitrolife is an international medical device Group. The Fertility product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes. Vitrolife has approximately 330 employees and the company’s products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm, Mid Cap.